ArticleCureus2025
Oncothermia and Integrative Medicine-A Novel Paradigm for Infratentorial Meningioma Management: A Case Report With One-Year Follow-Up.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Perspective on Integrative Oncology in India: Survival Conversations, Multidisciplinary Collaboration, and Healing Environments.Integrative medicine (Encinitas, Calif.) · 2026Review
- Integrative oncology along with systemic cancer therapies in advanced bladder and prostate cancer: metabolic optimization guiding the shift from palliative care to clinical remission - a case report.Frontiers in oncology · 2026Article
- Antioxidant Food Supplementation in Cancer: Lessons from Clinical Trials and Insights from Preclinical Studies.Antioxidants (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infratentorial meningiomas (IM) pose unique challenges in treatment due to their location and proximity to critical neurovascular structures such as cranial nerves, arteries, veins, etc. This case report presents the efficacy of an integrative medicine approach in managing IM, highlighting the multidisciplinary collaboration of modern medicine, yoga, naturopathy, and homeopathy. A 60-year-old male with IM, deemed unsuitable for surgery, underwent a tailored integrative medicine protocol involving oncothermia, ozone therapy, high-dose vitamin C, hydrogen inhalation, time-restricted feeding, hydrotherapy, biologicals, acupuncture, and yoga. Follow-up assessments revealed significant symptom reduction, stable biochemical markers, and tumor size reduction observed in MRI scans. While individual modalities have demonstrated benefits in cancer care, this case underscores the potential of integrating diverse therapies to address the multifaceted challenges of IM. The findings offer valuable insights into the evolving landscape of integrative medicine in brain tumor management, suggesting promise for improved patient outcomes and enhanced quality of life. Further research and clinical trials are warranted to comprehensively evaluate the safety and efficacy of integrative approaches in IM treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.